Company: SHPH
Filing Date: 2025-03-19
Form Type: PRE 14A
Source: 0001493152-25-010886
Chunk: 36

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-19
Form: PRE 14A
Chunk 36
---
 your shares are held by a broker and you do not give the broker specific instructions on how to vote your shares, your broker may vote your shares at its discretion on “routine” matters to be acted upon at the Annual Meeting. However, your shares will not be voted on any “non-routine” matters. An absence of voting instructions on any “non-routine” matters will result in a “broker non-vote.”

The only “routine” matter to be acted upon at the Annual Meeting is:

The Company expects that the Reverse Stock Split proposal will be treated as a non-routine matter, which means that your broker or other nominee will not have discretionary authority to vote your shares held in street name on this matter. Accordingly, in the absence of your voting instructions, your broker or nominee may not vote your shares on Proposal 4. Accordingly, all other matters to be acted upon at the Annual Meeting are “non-routine” matters. As such, if you hold all or any portion of your shares in street name and you do not give your broker or bank specific instructions on how to vote your shares, your shares will not be voted on the following “non-routine” matters:

| ● | Proposal                                                                                                                          
 1: Election of the five directors named in this proxy statement.                                                                  |
| ● | Proposal                                                                                                                          
 3: Approval (on an advisory basis) of the Company’s executive compensation.                                                       |
| ● | Proposal                                                                                                                          
 4: Authorization of the Board of Directors to amend the Company’s amended and restated certificate of incorporation to effect     
 a Reverse Stock Split of all of the Company’s issued and outstanding common stock by a ratio in the range of 1-for-3 to 1-for-10. |

What is the effect of giving a proxy?

Whichever method you use to transmit your voting instructions, your shares of Shuttle Pharmaceuticals common Stock will be voted as you direct. If you designate the proxy named on the proxy card to vote on your behalf, but do not specify how to vote your shares, they will be voted as follows:

| ● 
 ● | Proposal                                                                                                                          
 1: FOR ALL NOMINEES for the election of directors.                                                                                
 Proposal                                                                                                                          
 2: FOR the ratification of the appointment of Forvis Mazars, LLP as the Company’s independent auditor for the fiscal              
 year ending December 31, 2025.                                                                                                    |
|:--|:----------------------------------------------------------------------------------------------------------------------------------|
| ● | Proposal                                                                                                                          
 3: FOR